We found that small molecules CHIR99021 and VPA greatly improved the performance of GFP /iPS like colony generation so that around 30 iPS colonies were generated from 1 104 MEFs within 15 days after infection. The introduction of four transcription factors, Oct4, Klf4, Sox2 and c Myc, by viral transduction can induce the reprogramming of somatic cells into induced pluripotent stem cells, which resemble embryonic stem cells. The iPS technique represents a development in the stem cell area and provides a promising cell reference to Adriamycin ic50 for tailored patient-specific cell treatments. But, the medical applications of iPSCs are hindered by the potential risks of genetic mutation induced by the integration of exogenous genetic material into chromosomes. Although a few nonintegrative have been designed to create iPSCs, induction performance remains rather low. However, recent reports suggest the efficiency can be enhanced by the presence of small molecules, such as butyrate, AZA, valproic acid and vitamin D. Moreover, two small molecule inhibitors, PD0325901 and CHIR99021, were found to enhance the efficiency and achievement of re-programming process. Essentially, some small molecules have also been reported to be able to replace some transcription facets in generation. For instance, Mitochondrion a G9a inhibitor, BIX01294, was claimed to induce iPSCs from neural stem cells, in place of Oct4. Even though the underlying mechanism is still uncertain, kenpaullone could substitute for Klf4. In addition, a transforming growth factor B chemical might change Sox2 throughout iPSC technology. Up to now, at the least two transcription facets, Oct4 and Klf4, are still needed to create iPSCs from fibroblasts in the presence of the TGF B receptor inhibitor. Thus, it became of extreme interest to analyze whether the element exogenous transcription facets could be further removed to attain total chemical reprogramming by novel small molecules or novel mixtures of small molecules that help reprogramming. In this work, we discovered that a specific small molecule combination relieved the necessity supplier 2-ME2 for c Myc and Sox2, Klf4 and activated mouse fibroblasts in to iPSCs within the presence of a single transcription factor, Oct4. Our finding takes one-step closer to the generation of iPSCs by small molecules without the genetic modification, and offers a unique program for future testing to identify small molecules that may further replace the necessity for exogenous expression of Oct4. Technology of iPSCs with Oct4 and chemical combinations Within our preliminary experiments, we isolated OG MEFs from OG transgenic mice, that have an Oct4 GFP reporter system to reveal the pluripotent status OG MEFs were transduced with lentiviral vectors expressing Oct4/ Sox2/Klf4 and cultured in the presence of a few selected small substances reported to facilitate reprogramming.